SYNAGIS® (PALIVIZUMAB) for Intramuscular Administration

0 Downloads 24 Views

Other adverse events reported in more than 1% of the Synagis® (palivizumab) group included: fever, cough, wheeze, bronchiolitis, pneumonia, bronchitis, asthma, croup ...

Comments